Ch. 10 Flashcards

1
Q

What is the first, second, & third site of hematopoiesis in a developing embryo/fetus?

A

Yolk sac, then the AGM, then placenta and fetal liver, and finally the bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the predominant subtype of B cells made in a developing embryo/fetus?

A

• B cells generated from the fetal liver are predominantly B-1 cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do the B-1 cells differ from the predominant subtype made in adult bone marrow?

A

o Look similar, but have different receptors
o Abs from B-1 cells are cross-reactive and bind to carbohydrate antigens found on many pathogenic species
 Minimal receptor diversity
o Primarily located in body cavities (protect the gut and lungs)
o Self-renewing, even outside of bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

By the age of 18, where are the major sites of hematopoiesis?

A

By 18, the major sites of hematopoiesis are in the tibia, femur, pelvis, ribs, and sternum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does the hematopoiesis ability change over time as we age?

A

The ability to make B cells declines with age due to…

  1. Stromal cells less effective in secreting cytokines
  2. B-cell progenitors less able to respond to cytokines
  3. Stem cells start to lose self-renewal ability
  4. Rag1/2 and surrogate light-chain λ5 expression goes down
  5. A lifetime of B-cell activations diminishes room in follicles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the three goals of B-cell development?

A
  1. Generate a diverse antigen receptor
  2. Alter or eliminate self-reactive B-cells/B-cell receptors
  3. Promote foreign reactive B cells to become mature B cells in the secondary lymphoid tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What factors are produced by bone marrow stromal cells that facilitate B-cell development?

A
  1. Make contact with cells through cell-adhesion molecules (CAMs), VLA-4/VCAM
  2. Produce growth factors for the attached CLP
    a. IL-7, stem cell factor (SCF) c-KIT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the 1st checkpoint of B-cell development?

A

Large pre-B cell is an important stage, where the heavy chain is expressed with surrogate light chain as a pre-B-cell receptor
• Successful signaling= proliferation
o Why is this a good thing?
 Trying to maximize success; it is hard to make heavy chain recombination work, most will die.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the 2nd checkpoint of B-cell development?

A
Loci failures result in additional loci being attempted
•	Light chain gene rearrangement
o	Rearrange k on 1st chromosome
o	Rearrange k on 2nd chromosome
o	Rearrange λ on 1st chromosome
o	Rearrange on λ 2nd chromosome
•	If fail, apoptosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What three possible outcomes occur when B cells are autoreactive?

A
  1. Autoreactive B cells may undergo receptor editing
    a. Reactivation of recombination machinery
  2. Clonal deletion of strongly autoreactive cells
    a. Through apoptosis
    b. Termed central tolerance (bone marrow) or peripheral tolerance (spleen)
    c. 55-75% of immature autoreactive B cells lost this way
  3. Anergy- autoreactive T1 B cells that leave bone marrow can become anergic
    a. Bind to antigen without costimulatory signals  induction of nonresponsiveness to further stimuli (even self-antigen stimuli)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What results when central tolerance & peripheral tolerance mechanisms fail?

A

When tolerance mechanisms fail, autoreactive B cells can cause autoimmune diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The upregulation of BAFF & Bcl-XL are hallmarks of T2 cells as they mature into B-2 cells. What do these proteins do in cells?

A
  • No longer die in response to these stimuli due to increase in anti-apoptotic molecule Bcl-XL
  • Unknown molecule delivers a stimulatory signal that positively selects T2 cells to increase BAFF receptor (B-cell survival/activating factor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where in the spleen are T1 B cells located?

A

periarteriolar lymphoid sheath (PALs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where are T2 B cells located?

A

follicles of spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where would you find mature B-2 cells in SLOs?

A

secondary lymphoid follicles (follicular B cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where would you find the largest populations of B-2 cells?

A

secondary lymphoid organs

17
Q

Where would you find the largest populations of B-1 cells?

A

peritoneal and pleural cavities

18
Q

Where would you find the largest populations of MZ B cells?

A

marginal zones of spleen

19
Q

Where is the source of new B cells in adults for B-1 cells?

A

self-renewing (division of existing B-1 cells)

19
Q

Where is the source of new B cells in adults for B-2 cells?

A

HSC in bone marrow

20
Q

Where is the source of new B cells in adults for MZ B cells?

A

from HSCs in bone marrow, long lived

21
Q

Which B cell subset has high mIgD expression

A

B-2 B cells

22
Q

Which B cell subset(s) have high mIgM expression?

A

B-1 B cells and MZ B cells

23
Q

What is the main difference between B-1a and B-1b cells?

A

B-1a cells develop in the fetal liver whereas B-1b cells develop in adults

24
Q

Where do B-1a and B-1b B cells reside?

A

populate different anatomic niches than B-2 cells; 30-50% in pleural and peritoneal cavities in mice; 2% of splenic B-cell population

25
Q

Which B cell subset(s) primarilysecrete IgM in response to stimulation?

A

B-1 B cells and MZ B cells

26
Q

Which B cell subset(s) primarily secrete IgG in response to stimulation?

A

B-2 B cells

27
Q

Which B cell subset is likely the first to respond to a blood-borne bacterial infection?

A

MZ Bcells because they primarily make IgMantibody to blood borne antigens and can also activate without T cell help

28
Q

Which B cell subset is likely the first to respond to a bacterial infection in your peritoneum?

A

B-1 B cells because they reside within peritoneal and pleural cavities

29
Q

What are ways in which B- and T-cell development is different?

A

• Location of maturation and screening
o T cells= first stages in bone marrow, but then travel to mature in thymus
o B cells=most in bone marrow, but then mature in spleen
• Screening processes used
o T cells= positive and negative selection
o B cells= negative selection
• Specific arrangements and identities of gene segments recombined together
o T cells= heavy chain, kappa and lambda light chains
o B cells= delta and gamma
• T cells require presentation and differentiate into helper or killer subsets
• Only some B cells require T-cell help and all secrete antibodies
o Only B-2 requires T-cell help

30
Q

What are ways in which B- and T-cell development is similar?

A

• Share early phases of their developmental program (HSC to CLP)
• Rearrangement of gene loci for receptors
• Screening processes to avoid self-reactivity
o Ex. Negative selection
• Production of small subsets with discrete functions
o T cells= cytotoxic, helper, regulatory
o B cells= B-1, B-2, and MZ B cells
• Production of more innate, “general purpose” subsets
o T cells= regulatory cells
o B cells= B-1b or MZ B cells

31
Q

Where do B-1a and B-1b cells reside in the body?

A

Populate different anatomic niches (body cavities) than B-2 cells; 30-50% in pleural and peritoneal cavities in mice s; 2% of splenic B-cell population

32
Q

B-1 cell BCR diversity

A

B-1 B cells have a relatively limited receptor repertoire
• Some heavy- and light- chain gene segments predominantly rearranged and low TdT expression leads to lack of N-nucleotide diversity
• Receptors tend to bind microbial carbohydrate antigens
o Similar to PRRs of innate immunity